PLUS THERAPEUTICS, INC.·4

Apr 28, 7:00 AM ET

HEDRICK MARC H 4

4 · PLUS THERAPEUTICS, INC. · Filed Apr 28, 2022

Insider Transaction Report

Form 4
Period: 2022-04-27
HEDRICK MARC H
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-04-26$0.68/sh+2,500$1,71028,580 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $0.6841 or $0.6879 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION